Literature DB >> 21798285

Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Antonia Serrano1, Loren H Parsons.   

Abstract

The endogenous cannabinoid system is an important regulatory system involved in physiological homeostasis. Endocannabinoid signaling is known to modulate neural development, immune function, metabolism, synaptic plasticity and emotional state. Accumulating evidence also implicates brain endocannabinoid signaling in the etiology of drug addiction which is characterized by compulsive drug seeking, loss of control in limiting drug intake, emergence of a negative emotional state in the absence of drug use and a persistent vulnerability toward relapse to drug use during protracted abstinence. In this review we discuss the effects of drug intake on brain endocannabinoid signaling, evidence implicating the endocannabinoid system in the motivation for drug consumption, and drug-induced alterations in endocannabinoid function that may contribute to various aspects of addiction including dysregulated synaptic plasticity, increased stress responsivity, negative affective states, drug craving and relapse to drug taking. Current knowledge of genetic variants in endocannabinoid signaling associated with addiction is also discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798285      PMCID: PMC3209522          DOI: 10.1016/j.pharmthera.2011.06.005

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  544 in total

1.  The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction.

Authors:  Jonathan M Flanagan; Alexandra L Gerber; Jean Lud Cadet; Ernest Beutler; Jack C Sipe
Journal:  Hum Genet       Date:  2006-09-14       Impact factor: 4.132

Review 2.  Presynaptic modulation by endocannabinoids.

Authors:  David M Lovinger
Journal:  Handb Exp Pharmacol       Date:  2008

3.  Regional heterogeneity for the intracranial self-administration of ethanol within the ventral tegmental area of female Wistar rats.

Authors:  Z A Rodd-Henricks; D L McKinzie; R S Crile; J M Murphy; W J McBride
Journal:  Psychopharmacology (Berl)       Date:  2000-04       Impact factor: 4.530

4.  Effects of SR141716A on ethanol and sucrose self-administration.

Authors:  C S Freedland; A L Sharpe; H H Samson; L J Porrino
Journal:  Alcohol Clin Exp Res       Date:  2001-02       Impact factor: 3.455

5.  The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys.

Authors:  Zuzana Justinova; Gianluigi Tanda; Patrik Munzar; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

6.  CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.

Authors:  Astrid Cannich; Carsten T Wotjak; Kornelia Kamprath; Heike Hermann; Beat Lutz; Giovanni Marsicano
Journal:  Learn Mem       Date:  2004 Sep-Oct       Impact factor: 2.460

7.  The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats.

Authors:  P Adamczyk; A C McCreary; E Przegalinski; P Mierzejewski; P Bienkowski; M Filip
Journal:  J Physiol Pharmacol       Date:  2009-09       Impact factor: 3.011

8.  Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence.

Authors:  Arpana Agrawal; Leah Wetherill; Danielle M Dick; Xiaoling Xuei; Anthony Hinrichs; Victor Hesselbrock; John Kramer; John I Nurnberger; Marc Schuckit; Laura J Bierut; Howard J Edenberg; Tatiana Foroud
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-07-05       Impact factor: 3.568

9.  Pharmacological activation of CB1 and D2 receptors in rats: predominant role of CB1 in the increase of alcohol relapse.

Authors:  Francisco Alen; Guillermo Moreno-Sanz; Ana Isabel de Tena; Rayna D Brooks; Alejandro López-Jimenez; Miguel Navarro; José Antonio López-Moreno
Journal:  Eur J Neurosci       Date:  2008-06-01       Impact factor: 3.386

10.  The incentive salience of alcohol: translating the effects of genetic variant in CNR1.

Authors:  Kent E Hutchison; Heather Haughey; Michelle Niculescu; Joe Schacht; Alan Kaiser; Jerry Stitzel; William J Horton; Francesca Filbey
Journal:  Arch Gen Psychiatry       Date:  2008-07
View more
  63 in total

Review 1.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

2.  Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala.

Authors:  Florence P Varodayan; Michal Bajo; Neeraj Soni; George Luu; Samuel G Madamba; Paul Schweitzer; Marisa Roberto
Journal:  Addict Biol       Date:  2016-01-20       Impact factor: 4.280

Review 3.  Physiological processes underlying organ injury in alcohol abuse.

Authors:  Flavia M Souza-Smith; Charles H Lang; Laura E Nagy; Shannon M Bailey; Loren H Parsons; Gary J Murray
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-19       Impact factor: 4.310

Review 4.  Neurochemical and neurostructural plasticity in alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  ACS Chem Neurosci       Date:  2012-04-16       Impact factor: 4.418

5.  Acute ethanol exposure reduces serotonin receptor 1A internalization by increasing ubiquitination and degradation of β-arrestin2.

Authors:  Deborah J Luessen; Haiguo Sun; Molly M McGinnis; Michael Hagstrom; Glen Marrs; Brian A McCool; Rong Chen
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

Review 6.  Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Authors:  Nimish Sidhpura; Loren H Parsons
Journal:  Neuropharmacology       Date:  2011-06-12       Impact factor: 5.250

Review 7.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

8.  Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid.

Authors:  John Merrick; Brian Lane; Terri Sebree; Tony Yaksh; Carol O'Neill; Stan L Banks
Journal:  Cannabis Cannabinoid Res       Date:  2016-04-01

9.  The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food.

Authors:  Riccardo Dore; Marta Valenza; Xiaofan Wang; Kenner C Rice; Valentina Sabino; Pietro Cottone
Journal:  Addict Biol       Date:  2013-04-16       Impact factor: 4.280

Review 10.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.